A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
This commentary refers to 'Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum', by T. Lüscher et al., https:// doi.org/10.1093/eurheartj/ehab642.doi:10.1093/eurheartj/ehac219 pmid:35678582 fatcat:lxrmxdsmm5czvafbdf677fk2ta